company supported by the first lady of Conn. to quit COVID testing | Connecticut News


HARTFORD, Connecticut (AP) – A healthcare firm whose investors include a venture capital firm led by Connecticut’s first lady will quit COVID-19 testing business after questions have been raised over the contracts it ‘she received to manage state test sites.

The CT Mirror reported on Friday that Sema4, the company backed by Annie Lamont’s venture capitalist, told public health officials and investors that it would quit COVID testing in mid-January and return to its core business, genomic testing.

Stamford-based Sema4 said in a statement the testing landscape has changed dramatically, with more lab capacity and testing options than at the start of the pandemic, and that “now is the appropriate time. to devote our resources to the main mission of Sema4 “.

Gov. Ned Lamont said last month that his wife’s investment had yet to generate a profit, but any income she made would go to 4-CT, an independent, non-profit charity. created last year to address unmet needs caused by the pandemic.

Sema4 was awarded a $ 17.2 million contract from the state in July 2020 to provide COVID-19 testing and was subsequently awarded a non-tender contract worth $ 8.4 million to provide testing in long-term care facilities.

Political cartoons

He was also one of four companies the state hired in July to manage 23 COVID-19 test sites.

The CT Mirror reported that Annie Lamont’s company Oak HC / FT first invested in Sema4 in 2019, when the state, then headed by Governor Dannel P. Malloy, granted the company two start-up loans. She reinvested two months after her husband’s administration signed their first contract with the company, the CT Mirror reported.

Governor Lamont said his office had nothing to do with signing the contract, which was negotiated by the Office of the State Comptroller. The state ethics office found no conflict of interest with the contract.

Copyright 2021 Associated press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Comments are closed.